Skip to main content
Log in

An experimental study of vancomycin-induced cochlear damage

  • Original Investigations
  • Published:
Archives of oto-rhino-laryngology Aims and scope Submit manuscript

Summary

Vancomycin has been successfully used clinically for many years. Although early reports found ototoxicity to be a side effect of this antibiotic, later studies could not confirm this. For this reason we have started an experimental study in an animal model on the ototoxic effects of vancomycin. We now report the results of this study. Fourteen healthy Mongolian gerbils were treated with intraperitoneal injections of vancomycin (80 mg/kg per day) for a 2-week period. Before and after treatment each animal's hearing was evaluated by evoked response audiometry. Post mortem the cochleae were investigated by scanning electron microscopy in Amsterdam and by microdissection with surface preparations (hair cell counting) in Stockholm. The results of this study show that there is no clear evidence for the existence of ototoxicity due to vancomycin in this dosage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brummett RE (1981) Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity. Rev Infect Dis [Suppl] 3:216–223

    Google Scholar 

  2. Cook FV, Farrar WE (1978) Vancomycin revisited. Ann Intern Med 88:813–818

    Google Scholar 

  3. Davis RR, Brummett RE, Bendrick TW, Himes DI (1982) The ototoxic interaction of viomycin, capreomycin and polymyxin B with ethacrynic acid. Acta Otolaryngol (Stockh) 93:211–217

    Google Scholar 

  4. Dutton AAC, Elmes PC (1959) Vancomycin: report on treatment of patients with severe staphylococcal infection. Br Med J 1:1144–1149

    Google Scholar 

  5. Geraci JE, Heilman FR, Nichols DR, Wellman WE (1958) Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis. Proc Mayo Clin 33:172–181

    Google Scholar 

  6. Kavanagh KT, McCabe BF (1983) Ototoxicity of oral neomycin and vancomycin. Laryngoscope 93:649–653

    Google Scholar 

  7. Mellor JA, Kingdom J, Cafferkey M, Keane CT (1984) Vancomycin ototoxicity in patients with normal renal function. Br J Audiol 18:179–180

    Google Scholar 

  8. Mellor JA, Kingdom J, Cafferkey M, Keane CT (1985) Vancomycin toxicity: a prospective study. J Antimicrob Chemother 15:773–780

    Google Scholar 

  9. Schaad UB, Nelson JD, McCracken GH (1981) Pharmacology and efficacy of vancomycin for staphylococcal infection in children. Rev Infect Dis [Suppl] 3:282–288

    Google Scholar 

  10. Sorrel TC, Collignon PJ (1985) A prospective study of the adverse reactions associated with vancomycin therapy. J Antimicrob Chemother 16:235–241

    Google Scholar 

  11. Tange RA, Conijn EAJG, Zeijl LPGM van, Huizing EH (1982) Pattern of gentamicin-induced cochlear degeneration in the guinea pig: a morphological and electrophysiological study. Arch Otorhinolaryngol 236:173–184

    Google Scholar 

  12. Traber PG, Levine DP (1981) Vancomycin ototoxicity in a patient with normal renal function. Ann Intern Med 95:458–460

    Google Scholar 

  13. Wenzel RP (1982) The emergence of methicillin resistant Staphylococcus aureus. Ann Intern Med 97:440–442

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tange, R.A., Kieviet, H.L., Marle, J.v. et al. An experimental study of vancomycin-induced cochlear damage. Arch Otorhinolaryngol 246, 67–70 (1989). https://doi.org/10.1007/BF00457456

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00457456

Key words

Navigation